Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Bora Pharmaceuticals Co Ltd (6472) Stock Price & Analysis

6472 Stock Chart & Stats

NT$399.50NT$10.50(2.70%)
At close: 12:30 AM EST
TWD 375TWD 400TWD 425TWD 450Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 354.50 - TWD 407.50
52-Week Range
TWD 330.50 - TWD 646.00
Previous Close
TWD 389.00
Volume
N/A
Average Volume (3M)
540.88K
Market Cap
TWD 51.14B
Enterprise Value
TWD 72.16B
Total Cash (Recent Filing)
TWD 8.49B
Total Debt (Recent Filing)
TWD 21.82B
Price to Earnings (P/E)
32.8
Beta
0.17
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
5.23
Last Dividend Ex-Date
Jul 31, 2026
Dividend Yield
2.50%

Bulls Say, Bears Say

Bulls Say

Solid Profitability

Bora retains a solid profitability profile, with substantial gross and net margins supporting internal funding and resilience. This earnings base can help the company invest in drug development, manufacturing capacity, regulatory compliance, and commercialization while maintaining meaningful shareholder returns.

Strong 2025 Cash Generation

The sharp 2025 recovery in operating and free cash flow strengthens Bora’s ability to fund operations, capital investment, debt service, and strategic initiatives. Free cash flow covering approximately 78% of net income also provides useful support for earnings quality and financial flexibility.

Long-Term Revenue Expansion

Bora has demonstrated meaningful revenue expansion across the 2020–2025 period, indicating that its pharmaceutical development, manufacturing, and commercialization platform has grown over time. That broader scale can support customer reach, operating leverage, and a stronger competitive position.

Bears Say

Recent Revenue And Earnings Decline

The latest contraction in revenue and decline in net income indicate that Bora’s recent earnings momentum has weakened after prior growth. If this persists, slower demand or product performance could reduce reinvestment capacity and make future profit expansion less dependable.

Margin Compression

Meaningful margin compression reduces the amount of profit generated from each unit of revenue and can weaken the durability of Bora’s earnings model. Continued pressure would limit operating leverage, constrain funding for development and commercialization, and make results more sensitive to revenue changes.

Elevated Leverage

Elevated leverage increases Bora’s financial risk even though debt-to-equity improved from 2024. A debt-heavy balance sheet can raise debt-service demands, reduce flexibility for expansion or acquisitions, and leave the company less able to absorb prolonged earnings or cash-flow weakness.

6472 FAQ

What was Bora Pharmaceuticals Co Ltd’s price range in the past 12 months?
Bora Pharmaceuticals Co Ltd lowest stock price was TWD 330.50 and its highest was TWD 646.00 in the past 12 months.
What is Bora Pharmaceuticals Co Ltd’s market cap?
Bora Pharmaceuticals Co Ltd’s market cap is TWD 51.14B.
When is Bora Pharmaceuticals Co Ltd’s upcoming earnings report date?
Bora Pharmaceuticals Co Ltd’s next earnings report is estimated for Nov 18, 2026 (not yet confirmed), which is in 8 days.
How were Bora Pharmaceuticals Co Ltd’s earnings last quarter?
Bora Pharmaceuticals Co Ltd released its earnings results on Aug 13, 2026. The company reported TWD 4.355 earnings per share for the quarter, missing the consensus estimate of TWD 5.054 by -TWD 0.699.
Is Bora Pharmaceuticals Co Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bora Pharmaceuticals Co Ltd pay dividends?
Bora Pharmaceuticals Co Ltd pays a ― dividend of TWD 10 which represents an annual dividend yield of 2.5%. See more information on Bora Pharmaceuticals Co Ltd dividends here
What is Bora Pharmaceuticals Co Ltd’s EPS estimate?
Bora Pharmaceuticals Co Ltd’s EPS estimate is 5.23.
How many shares outstanding does Bora Pharmaceuticals Co Ltd have?
Bora Pharmaceuticals Co Ltd has 128,019,120 shares outstanding.
What happened to Bora Pharmaceuticals Co Ltd’s price movement after its last earnings report?
Bora Pharmaceuticals Co Ltd reported an EPS of TWD 4.355 in its last earnings report, missing expectations of TWD 5.054. Following the earnings report the stock price went down -0.472%.
Which hedge fund is a major shareholder of Bora Pharmaceuticals Co Ltd?
Currently, no hedge funds are holding shares in TW:6472
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology